Patent · US Active

Compounds for the treatment of proliferative disorders

US9102601B2 · kind B2 · utility

0Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2014
Grant dateAug 11, 2015
Priority date
Expiry dateJul 21, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds and pharmaceutical compositions that are useful for treating a subject with a proliferative disorder, such as cancer. The disclosed compounds and pharmaceutical compositions are also useful for treating disorders responsive to Hsp70 induction and/or natural killer induction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.